Autor: |
Griffin, Riley, Baumann, Jeannie |
Předmět: |
|
Zdroj: |
Bloomberg.com; 12/14/2021, p1-1, 1p |
Abstrakt: |
With the limited treatment options currently available for Covid patients, being prompt is more important than being precise, said Anu Osinusi, Gilead's vice president of clinical research for hepatitis, respiratory and emerging viruses. Keywords: 1394003D; 3411161Z; 596856Z; ADGI; GILD; REGN; TMO; ALLTOP; BUSINESS; CORONAVIR; COS; DRG; EXE; GEN; GENTOP; GOV; HEA; INDUSTRIES; MARKETS; NORTHAM; STK; TOP; US; WORLD; WWTOP; WWTOPAM EN 1394003D 3411161Z 596856Z ADGI GILD REGN TMO ALLTOP BUSINESS CORONAVIR COS DRG EXE GEN GENTOP GOV HEA INDUSTRIES MARKETS NORTHAM STK TOP US WORLD WWTOP WWTOPAM (Bloomberg) -- The omicron variant presents a new problem for doctors: Some drugs may work better than others, but knowing what to prescribe will hinge on quickly figuring out what variant of Covid-19 a person has in the first place. Right now, doctors don't treat Covid patients based on which mutation of the virus has infected them. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|